Table I.
Baseline characteristics of all patients.
| Characteristics | Value |
|---|---|
| Age (years) | 56.8±12.5 |
| Gender (M/F) | 99/39 |
| Presence of DM (yes/no) | 34/104 |
| NLR (≥5/<5) | 46/92 |
| Child-Pugh class (A/B) | 105/33 |
| Maximum tumor diameter (cm) | 8.7±4.5 |
| No. of tumors (single/multiple) | 63/75 |
| Presence of PVTT (yes/no) | 67/71 |
| No. of TACE procedures (1/≥1) | 115/23 |
| ALT (U/l) | 51.7±67.1 |
| AST (U/l) | 70.6±85.2 |
| Albumin (g/l) | 38.9±5.3 |
| TBIL (μmol/l) | 17.9±24.8 |
| ALP (U/l) | 200.4±170.3 |
| GGT (U/l) | 201.0±230.0 |
| AFP (ng/ml) | 7697.3±21041.3 |
| Platelet count (x109/l) | 189.9±96.1 |
| INR | 1.06±0.11 |
| NLR | 4.55±2.71 |
Values are presented as mean ± standard deviation or n. DM, diabetes mellitus; M, male; F, female; NLR, neutrophil to lymphocyte ratio; PVTT, portal vein tumor thrombus; TACE, transarterial chemoembolization; ALT, alanine aminotransferase; AST, aspartate aminotransferase; TBIL, total bilirubin; ALP, alkaline phosphatase; GGT, γ-glutamyl transpeptidase; AFP, α-fetoprotein; INR, international normalised ratio.